Your browser doesn't support javascript.
loading
Patient stratification for determining optimal second-line and third-line therapy for type 2 diabetes: the TriMaster study.
Shields, Beverley M; Dennis, John M; Angwin, Catherine D; Warren, Fiona; Henley, William E; Farmer, Andrew J; Sattar, Naveed; Holman, Rury R; Jones, Angus G; Pearson, Ewan R; Hattersley, Andrew T.
Afiliación
  • Shields BM; Department of Clinical and Biomedical Sciences, University of Exeter, Exeter, UK.
  • Dennis JM; Department of Clinical and Biomedical Sciences, University of Exeter, Exeter, UK.
  • Angwin CD; Department of Clinical and Biomedical Sciences, University of Exeter, Exeter, UK.
  • Warren F; Clinical Trials Unit, University of Exeter Medical School, Exeter, UK.
  • Henley WE; Institute of Health Research, University of Exeter Medical School, Exeter, UK.
  • Farmer AJ; Institute of Health Research, University of Exeter Medical School, Exeter, UK.
  • Sattar N; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
  • Holman RR; School of Cardiovascular & Metabolic Health, University of Glasgow, Glasgow, UK.
  • Jones AG; Diabetes Trials Unit, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
  • Pearson ER; Department of Clinical and Biomedical Sciences, University of Exeter, Exeter, UK.
  • Hattersley AT; Population Health & Genomics, School of Medicine, University of Dundee, Dundee, UK.
Nat Med ; 29(2): 376-383, 2023 02.
Article en En | MEDLINE | ID: mdl-36477733
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Inhibidores de la Dipeptidil-Peptidasa IV / Metformina Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Inhibidores de la Dipeptidil-Peptidasa IV / Metformina Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido